Quince Therapeutics Inc.
(QNCX)
undefined
undefined%
At close: undefined
2.03
0.00%
Pre-market Dec 16, 2024, 08:00 AM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -0.31 | -0.10 | -1.05 | -2.64 | -7.26 | -14.20 | -14.48 |
PS Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio | 0.11 | 0.05 | 0.79 | 1.18 | 2.31 | 2.48 | -8.74 |
P/FCF Ratio | -0.53 | -0.12 | -1.49 | -3.98 | -8.01 | -14.88 | -17.89 |
P/OCF Ratio | -0.53 | -0.12 | -1.49 | -3.99 | -8.03 | -15.15 | -18.03 |
OCF/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 |
Quick Ratio | 2.02 | 7.45 | 1.92 | 2.03 | 2.98 | 12.45 | 1.07 |
Current Ratio | 2.02 | 7.64 | 1.96 | 2.03 | 2.98 | 12.45 | 1.07 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | 0.00 | -22.89 | 0.00 | 0.00 | 0.00 | -3.17 | -1.58 |
Return on Equity (ROE) | -36.89% | -51.36% | -75.33% | -44.61% | -31.86% | -17.47% | 60.33% |
Return on Assets (ROA) | -18.69% | -49.72% | -67.05% | -40.56% | -29.58% | -17.12% | -158.53% |
Return on Capital (ROIC) | -21.87% | -51.58% | -75.89% | -45.74% | -33.92% | -16.97% | -174.14% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |